drugs for generalized anxiety disorder
A recent systematic review/network meta-analysis evaluated pharmacologic therapy for generalized anxiety disorder, GAD ( see generalized anxiety disorder meds lancet2019 in dropbox, or doi.org/10.1016/ S0140-6736(18)31793-8). A network meta-analysis is a combination of direct pharmacologic evidence (e.g. direct comparisons of different treatments within the same trials) plus indirect evidence (comparisons of treatments assessed across trials, typically with each trial being placebo-controlled, and comparing the magnitude of the drug effect). Details: -- 89 trials from 1994-2017 were included, with 25,441 patients assigned to 22 different active drugs or placebo -- all studies included the Hamilton Anxiety Scale (HAM-A, see below for details), with baseline baseline median HAM-A score of 25 (indicating moderate to severe GAD) -- 73 of the studies (82%) use the DSM criteria, which required a six-month duration of symptoms for the diagnosis of GAD -- 7 of ...